文献速递肾小球疾病遗传性与小管间质肾病

C3肾小球病与Ig相关MPGN中C3和C5转化酶失调的获得性与遗传驱动因素

Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN.
PubMed 文献 · Nephrol Dial Transplant · 2025-01-01

本文综述C3肾小球病(C3G)和原发性免疫球蛋白相关膜增生性肾小球肾炎(Ig-MPGN)中靶向替代途径的自身免疫和遗传因素。肾炎因子是最常见异常,单克隆丙种球蛋白病在老年人中常见,部分患者携带替代途径补体基因罕见变异。不同驱动因素提示可针对C3或C5转化酶活性上游或水平进行个体化治疗。

要点

  • 肾炎因子是C3G和Ig-MPGN中最常见的替代途径异常。
  • 单克隆丙种球蛋白病在老年患者中常见,可促进补体激活。
  • 部分患者携带替代途径补体基因罕见变异,驱动补体失调。

核心结论

  • C3G和Ig-MPGN存在多种靶向替代途径的获得性和遗传驱动因素,提示针对C3或C5转化酶活性的个体化治疗可能获益。

研究设计与样本

  • 综述,总结C3G和Ig-MPGN中靶向替代途径的自身免疫和遗传因素。

主要发现

  • 肾炎因子是靶向C3或C5转化酶的最常见异常,构成一组异质性自身抗体。
  • 单克隆丙种球蛋白病在老年成人中常见,可促进补体激活,部分靶向替代途径调节蛋白。
  • 部分C3G和Ig-MPGN患者携带编码替代途径补体激活或调节蛋白的基因罕见变异。

临床怎么用

  • 临床应评估C3G和Ig-MPGN患者的肾炎因子、单克隆丙种球蛋白病及替代途径基因变异。
  • 治疗策略可考虑针对C3或C5转化酶活性上游或水平的个体化方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dysregulation of the alternative pathway of complement plays a central role in the pathophysiology of C3 glomerulopathy (C3G). Various autoimmune and genetic factors targeting the alternative pathway have been associated with both C3G and primary immunoglobulin-associated membranoproliferative glomerulonephritis (Ig-MPGN), suggesting shared pathophysiological mechanisms. This review highlights the wide range of disease drivers identified that mainly target components or protein complexes of the alternative pathway, both in C3G and Ig-MPGN. Nephritic factors, which constitute a heterogeneous group of autoantibodies targeting the C3 or the C5 convertase, are the most common abnormalities. Monoclonal gammopathies are frequent in aging adults. They may promote complement activation and have in some cases also been found to target alternative pathway regulatory proteins. Additionally, some patients with C3G and Ig-MPGN carry rare variants in genes encoding complement activating or regulating proteins of the alternative pathway. This review provides an informative overview of pathogenetic mechanisms associated with each abnormality, acting at different steps in the complement cascade. The diversity of targets involved in the C3G pathophysiology suggests the potential benefit of therapeutical approaches tailored to the underlying disease drivers, with a pivotal impact upstream or at the level of the C3 or C5 convertase activity.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Roquigny J, Meuleman MS, El Sissy C, et al. Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN. Nephrol Dial Transplant. 2025. PMID: 39537194. doi:10.1093/ndt/gfae243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。